Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandi M Hopkins

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 25, 2017
Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cellsMandi M Hopkins, Kathryn E Meier
Handbook of Experimental Pharmacology|October 21, 2016
Free Fatty Acid Receptors and Cancer: From Nutrition to PharmacologyMandi M Hopkins, Kathryn E Meier
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2016
Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer CellsMandi M Hopkins, Ze Liu, Kathryn E Meier
Journal of Clinical Medicine|January 29, 2016
Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer CellsMandi M Hopkins, Zhihong Zhang, Ze Liu, et al.
Pharmaceutical Research|February 19, 2021
Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic SignaturesMandi M Hopkins, Arun Parupudi, Jared S Bee, et al.
International Journal of Oncology|March 12, 2015
Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cellsMandi M Hopkins, Xiaoxing Feng, Mengwei Liu, et al.
Pharmaceutical Research|March 3, 2023
Comparative Thermodynamics of the Reversible Self-Association of Therapeutic mAbs Reveal Opposing Roles for Linked Proton- and Ion-Binding EventsMandi M Hopkins, Ioanna H Antonopoulos, Arun Parupudi, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative AnalysisMandi M Hopkins, Cherie L Lambert, Jared S Bee, et al.
Molecular Cancer|July 31, 2012
Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapyXiaoxing Feng, Yiran Zhou, Alicia M Proctor, et al.
Oncology Reports|July 17, 2015
Enhanced cytotoxicity in triple-negative and estrogen receptor‑positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channelDavid W Koh, Daniel P Powell, Steven D Blake, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 25, 2017
Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cellsMandi M Hopkins, Kathryn E Meier
Handbook of Experimental Pharmacology|October 21, 2016
Free Fatty Acid Receptors and Cancer: From Nutrition to PharmacologyMandi M Hopkins, Kathryn E Meier
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2016
Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer CellsMandi M Hopkins, Ze Liu, Kathryn E Meier
Journal of Clinical Medicine|January 29, 2016
Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer CellsMandi M Hopkins, Zhihong Zhang, Ze Liu, et al.
Pharmaceutical Research|February 19, 2021
Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic SignaturesMandi M Hopkins, Arun Parupudi, Jared S Bee, et al.
International Journal of Oncology|March 12, 2015
Inhibition of the transient receptor potential melastatin-2 channel causes increased DNA damage and decreased proliferation in breast adenocarcinoma cellsMandi M Hopkins, Xiaoxing Feng, Mengwei Liu, et al.
Pharmaceutical Research|March 3, 2023
Comparative Thermodynamics of the Reversible Self-Association of Therapeutic mAbs Reveal Opposing Roles for Linked Proton- and Ion-Binding EventsMandi M Hopkins, Ioanna H Antonopoulos, Arun Parupudi, et al.
Journal of Pharmaceutical Sciences|March 25, 2018
Determination of Interaction Parameters for Reversibly Self-Associating Antibodies: A Comparative AnalysisMandi M Hopkins, Cherie L Lambert, Jared S Bee, et al.
Molecular Cancer|July 31, 2012
Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapyXiaoxing Feng, Yiran Zhou, Alicia M Proctor, et al.
Oncology Reports|July 17, 2015
Enhanced cytotoxicity in triple-negative and estrogen receptor‑positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channelDavid W Koh, Daniel P Powell, Steven D Blake, et al.
Pageof 2